Instrucciones de búsqueda:
* Filter the ENTIRE resource library: Choose a OR a to sort all resources.
* Choose Search Items : to filter one collection or perform complex queries.
* Choose Browse by Topic to search by one or more Topics.
Navegar por los elementos (92 total)
-
Autor: Haddad, Lisa B., Denise J. Jamieson, and Sonja A. Rasmussen.
Tema: Treatment & Care
Tipo de elemento: Publicación
Fecha de actualización: 2018-12-27
Descripción: On August 1, 2018, the Ministry of Health of the Democratic Republic of Congo (DRC) reported the emergence of another Ebola virus outbreak, the 10th in the DRC since the virus was discovered in 1976. As of November 13, 2018, there were 341 cases and… -
Autor: Ibarrondo, F. Javier, Jennifer A. Fulcher, David Goodman-Meza, Julie Elliott, Christian Hofmann, Mary A. Hausner, Kathie G. Ferbas, Nicole H. Tobin, Grace M. Aldrovandi, and Otto O. Yang.
Tema: Research
Tipo de elemento: Publicación
Fecha de actualización: 2020-07-21
Descripción: A recent article suggested the rapid decay of anti–SARS-CoV-2 IgG in early infection, but the rate was not described in detail. We evaluated persons who had recovered from Covid-19 and referred themselves to our institution for observational… -
Autor: Johns Hopkins Berman Institute of Bioethics, The Pregnancy Research Ethics for Vaccines, Epidemics, and New Technologies (PREVENT) Project
Tema: Research
Tipo de elemento: Publicación
Fecha de actualización: 2019-05-03
Descripción: PREVENT Guidance This Guidance provides a roadmap for the ethically responsible, socially just, and respectful inclusion of the interests of pregnant women in the development and deployment of vaccines against emerging pathogens. The Guidance is a… -
Autor: Kamar, Nassim, Florence Abravanel, Olivier Marion, Chloé Couat, Jacques Izopet, and Arnaud Del Bello.
Tema: Research
Tipo de elemento: Publicación
Fecha de actualización: 2021-06-23
Descripción: A weak immune response to two doses of vaccine against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been observed in recipients of solid-organ transplants. -
Autor: Keech, Cheryl, Gary Albert, Iksung Cho, Andreana Robertson, Patricia Reed, Susan Neal, Joyce S. Plested, Mingzhu Zhu, Shane Cloney-Clark, Haixia Zhou, Gale Smith, Nita Patel, Matthew B. Frieman, Robert E. Haupt, James Logue, Marisa McGrath, Stuart…
Tema: Research
Tipo de elemento: Publicación
Fecha de actualización: 2020-12-10
Descripción: NVX-CoV2373 is a recombinant severe acute respiratory syndrome coronavirus 2 (rSARS-CoV-2) nanoparticle vaccine composed of trimeric full-length SARS-CoV-2 spike glycoproteins and Matrix-M1 adjuvant. -
Autor: Keehner, Jocelyn, Lucy E. Horton, Michael A. Pfeffer, Christopher A. Longhurst, Robert T. Schooley, Judith S. Currier, Shira R. Abeles, and Francesca J. Torriani.
Tema: Research
Tipo de elemento: Publicación
Fecha de actualización: 2021-03-23
Descripción: Data from phase 3 clinical trials of messenger RNA (mRNA) vaccines through November 2020 showed 94.1% efficacy for the prevention of symptomatic severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection at 14 days after the second dose…Example only: NETEC provides this item for reference purposes but does not endorse its content. Newer versions may be in place at the providing institution.
-
Autor: Koch, Till, Christine Dahlke, Anahita Fathi, Alexandra Kupke, Verena Krähling, Nisreen M. A. Okba, Sandro Halwe, Cornelius Rohde, Markus Eickmann, Asisa Volz, Thomas Hesterkamp, Alen Jambrecina, Saskia Borregaard, My L. Ly, Madeleine E. Zinser,…
Tema: Laboratory
Tipo de elemento: Publicación
Fecha de actualización: 2020-04-20
Descripción: The Middle East respiratory syndrome coronavirus (MERS-CoV) causes a respiratory disease with a case fatality rate of up to 35%. -
Autor: Leshem, Eyal, and Benjamin Alan Lopman.
Tema: Infection Control
Tipo de elemento: Publicación
Fecha de actualización: 2021-04-23
Descripción: Vaccines act by two broad main mechanisms. They can block infection occurring entirely or they can halt the progression to symptoms after infection occurs. -
Autor: Li, L., L. B. Robinson, R. Patel, A. B. Landman, X. Fu, E. S. Shenoy, D. M. Hashimoto, A. Banerji, P. G. Wickner, U. Samarakoon, C. M. Mancini, Y. Zhang, and K. G. Blumenthal.
Tema: Research
Tipo de elemento: Publicación
Fecha de actualización: 2021-10-01
Descripción: Allergic history in individuals with confirmed anaphylaxis to a messenger RNA (mRNA) COVID-19 vaccine is common. However, the risk factors for allergy symptoms after receiving the vaccine are unknown. -
Autor: Liu, Yang, Jianying Liu, Hongjie Xia, Xianwen Zhang, Camila R. Fontes-Garfias, Kena A. Swanson, Hui Cai, Ritu Sarkar, Wei Chen, Mark Cutler, David Cooper, Scott C. Weaver, Alexander Muik, Ugur Sahin, Kathrin U. Jansen, Xuping Xie, Philip R.…
Tema: Research
Tipo de elemento: Publicación
Fecha de actualización: 2021-02-17
Descripción: BNT162b2 is a nucleoside-modified RNA vaccine expressing the full-length prefusion spike glycoprotein (S) of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). In a randomized, placebo-controlled clinical trial involving approximately…